1,822 Shares in Aflac Incorporated (NYSE:AFL) Bought by WorthPointe LLC

WorthPointe LLC acquired a new position in shares of Aflac Incorporated (NYSE:AFL) in the third quarter, HoldingsChannel.com reports. The institutional investor acquired 1,822 shares of the financial services provider’s stock, valued at approximately $204,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Y.D. More Investments Ltd acquired a new position in Aflac during the 2nd quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new stake in shares of Aflac in the third quarter worth $34,000. Covestor Ltd boosted its holdings in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the last quarter. Kennebec Savings Bank bought a new position in Aflac in the third quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in Aflac in the third quarter valued at $51,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the company. TD Cowen began coverage on Aflac in a research report on Wednesday, October 9th. They set a “hold” rating and a $102.00 price target for the company. UBS Group lifted their price objective on shares of Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, August 14th. Morgan Stanley raised their target price on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research note on Monday, August 19th. JPMorgan Chase & Co. upped their price objective on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, October 3rd. Finally, Wells Fargo & Company boosted their target price on Aflac from $106.00 to $107.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $97.93.

Aflac Price Performance

Aflac stock opened at $114.01 on Wednesday. The stock’s fifty day moving average price is $110.88 and its two-hundred day moving average price is $101.05. The firm has a market cap of $63.34 billion, a PE ratio of 17.17, a price-to-earnings-growth ratio of 2.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the previous year, the firm earned $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% compared to the same quarter last year. As a group, research analysts expect that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.75%. Aflac’s dividend payout ratio (DPR) is 30.12%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.